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Abstract
Background: The aim of this study was to determine the occurrence of extra-enteric findings in a large cohort of patients
undergoing magnetic resonance enterography (MR-E) and to classify the clinical significance of these findings.
Materials and Methods: We retrospectively analyzed 1154 MR-E performed in 1006 patients referred to our radiological
department between 1999–2005. The reasons for referral were suspected or proven inflammatory bowel diseases (IBD)
(n=710), further diagnostic work-up for small bowel disease because of non-specific abdominal symptoms (SBD; n=182) or
suspected small bowel malignancies (SBM; n=114). All extra-enteric findings were reviewed by a radiologist and a
gastroenterologist and were classified as having high, moderate, or low significance for further diagnostic or therapeutic
procedures.
Results: The average age of all patients was 40616 (Mean6SD) years (y) (IBD 35613 y; SBD 49616 y; SBM 57615 y). A total
of 1113 extra-enteric findings were detected in 600 of 1006 patients (59.6%). Of these findings 180 (16.2%) were judged as
having a high, 212 (19.0%) a moderate and 721 (64.8%) a low significance. On a per group basis in patients with IBD 12.0%
of the findings were of major clinical significance compared to 13.7% and 33.3% in patients with SBD and SBM, respectively.
The most common major findings were abscesses (69.9%) in the IBD group and extraintestinal tumors, metastases or
masses in the SBD and SBM groups (41.9% and 74.2%, respectively).
Conclusions: MR-E reveals a substantial number of extra-enteric findings, supporting the role of a cross-sectional imaging
method for the evaluation of the small bowel.
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Introduction
In patients with suspected or proven inflammatory bowel
disease, radiological imaging techniques of the small bowel are
employed to either establish or exclude the diagnosis of small
bowel Crohn’s disease or to evaluate the location, extent and the
presence of strictures of small bowel in patients with established
Crohn’s disease. Until recently, the small bowel follow-through or
the classical conventional enteroclysis have been the preferred
radiological technique for the visualization of the small bowel.
However, MR or CT based enterography or enteroclysis are more
and more considered as a standard imaging procedure in patients
with suspected or established inflammatory bowel diseases [1,2,3].
Especially the diagnostic value of MR imaging (MRI) of the small
bowel in patients with inflammatory bowel disease has been
extensively assessed in recent years using various contrast media
and different techniques [4,5,6,7,8,9,10,11,12,13,14,15]. Several
studies also demonstrated a high correlation of this technique with
conventional radiological methods such as small bowel follow-
through or conventional enteroclysis, surgery and endoscopy
[16,17,18,19,20,21,22,23].
The advantage of both CT and MRI as compared to
conventional radiological methods is the acquisition of additional
information of extraluminal pathologies. Studies comparing MRI
and conventional enteroclysis revealed additional pathological
extra-enteric abnormalities in 25–58% of the cases, which are
sometimes clinically relevant and lead to changes in medical or
surgical management [18,20,24,25,26,27]. All these studies have
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Additionally, the clinical significance of these extra-enteric
pathologies has never been evaluated.
Several studies analyzing the frequency and clinical significance
of extracolonic findings in patients undergoing virtual colono-
graphy for screening purposes have been recently published. A
systematic review of 17 studies including 3448 patients revealed
that up to 40% of the patients had extracolonic pathologies [28].
In this analysis clinical significant findings necessitating further
diagnostic or therapeutic work-up were described in 10.5% in a
subgroup of 2787 patients. Since patients with IBD in general
present at a younger age than patients undergoing screening
colonography (age .50 years) and therefore most likely suffer from
less comorbidity, we evaluated the prevalence and clinical
significance of extraintestinal findings in this patient group. For
this purpose we retrospectively analyzed all extra-enteric findings
in patients referred to our institution for MR-E between 1999–
2005 because of suspected or established IBD. We additionally
included two other groups of patients undergoing MR-E for
unexplained abdominal symptoms without clinical suspicion of
inflammatory bowel disease and patients with suspected small
bowel tumors. The aim of this study was to determine the
frequency of extra-enteric findings in these three groups and to
classify the clinical significance of these findings.
Materials and Methods
We retrospectively analyzed the extra-enteric findings of 1154
MR-E performed in 1006 patients referred to our radiological
department between 1999–2005. The institutional review board of
the University of Regensburg approved the study. The reasons for
referral were highly suspected (based on previous evaluations often
including colonoscopy) or proven inflammatory bowel disease
(IBD) (n=710), further diagnostic work-up for a suspected small
bowel disease (SBD) because of non-specific abdominal symptoms
(n=182) or suspected small bowel malignancies (SBM) (n=114).
All extra-enteric findings were reviewed by a radiologist and a
gastroenterologist and were classified as having minor, moderate,
or major significance.
Employing a previously published classification by Hellstrom et
al., findings considered to be of no or little clinical importance
were classified as minor and unlikely to require further diagnostic
procedures or medical therapy [29]. Examples include e.g. small
cystic liver lesions, renal cysts, small renal calcifications or
degenerative changes of the spine. Findings of moderate clinical
importance did not require immediate further diagnostic workup
or therapy, but would likely to be verified later on either by chart
review or by further clinical or radiologic follow up. Examples
include adrenal masses of ,2 cm in diameter, indeterminate cysts
of various organs, gallstones, splenomegaly. Findings of definite
clinical importance requiring immediate further diagnostic or
therapeutic intervention (e.g. hydronephrosis, suspected tumors,
aortal aneurysms, pleural effusions) were classified as being of
major clinical importance.
MR-E
All MRI examinations were performed using a 1.5T Scanner
(Symphony; Siemens Medical Systems, Erlangen, Germany) and a
circular polarized 4-element phased array body coil. For the
abdominal MR-E performed between 1999–2001 the patient
drank 2 l of pineapple juice (12.7 mg/l manganese-content) mixed
with 20 mg methylcellulose within 2 hours for bright lumen MRE
[15]. After 2002 the dark lumen technique [30] was utilized. For
this technique the patients drank 2 liters of tap water during
1 hour continuously. To achieve sufficient small bowel distension
we added 50 g mannitol and 5 g carob seed (Nestargel, Nestle,
Munich, Germany) to 1-liter water. To reduce bowel peristalsis,
patients without contraindications received 40 mg N-butyl-sco-
polamine intravenously (Buscopan; Boehringer, Ingelheim, Ger-
many) in 100 mL 0.9% NaCl continuously during the examina-
tion as drip infusion. For the bright lumen as well as the dark
lumen MRE the same MRI sequences were applied.
As a fast screener sequence a coronal true fast imaging with
steady precession (TRUFI; TR/TE, 4.76/2.38 msec; flip angle,
60 degrees; slice thickness, 5 mm; 256 matrix; FOV, 450 mm) and
an axial half-Fourier acquired single-shot turbo spin echo
(HASTE; TR/TE, 1070/77 msec; flip angle, 150 degrees; slice
thickness, 8 mm; 256 matrix; FOV, 400 mm) as a T2-weighted
sequence were acquired. Before injecting contrast media intrave-
nously, a T1-weighted 2D-FLASH sequence with axial orientation
was performed, which was used as a baseline sequence for contrast
uptake. Afterward, 0.2 mmol/kg body weight Gd-DTPA (Mag-
nevist; Schering, Berlin, Germany) with a flow of 2 mL/sec was
given intravenously followed after 70 seconds by a fat-suppressed
axial 3D-FLASH sequence (TR/TE, 4.6/1.8 msec; flip angle,
25 degrees; slab thickness, 140 to 160 mm with 80 partitions;
5126210 matrix; FOV, 400 mm). Additionally a fat-suppressed
axial and coronal T1-weighted 2D-FLASH was acquired. Scanner
time for the whole examination was approximately 25 minutes
(range, 21 to 29 min).
Results
539 of the 1006 patients included in this study were females
(54%). The youngest patient was 11 years and the oldest 90 years
old. The average age 6SD in the patient group referred for IBD
(n=710), SBD (n=182) and SBM (n=114) were 35613, 49616
and 57615 years, respectively.
Radiological classification of extra-enteric pathologies in
patients with IBD, SBD and SBM
Overall 1113 extra-enteric findings were detected in 600 of
1006 patients (59.6%). Of these 689, 226 and 198 extra-enteric
findings were detected in 403 of 710 (56.8%), 119 of 182 (65.4%)
and 78 of 114 (68.4%) patients with IBD, SBD and SBM,
respectively (table 1).
Extra-enteric findings of minor and moderate clinical
significance
Overall 470, 156 and 95 findings of minor clinical significance
were detected in patients with IBD, SBD and SBM, respectively.
Most commonly ovarian-, kidney-and liver cysts were described in
8–25% of the patients (table 2). 136, 39 and 37 findings of
moderate clinical significance were detected in patients with IBD,
SBD and SBM, respectively. The most common findings were
chlecysto- or choledocholithiasis, degenerative bone disease and
lymphadenopathy, which was considered as not suspicious for
intestinal lymphoma (table 3).
Extra-enteric findings of major clinical significance
Overall 180 findings were considered being of major clinical
significance (see also table 1). The most common highly significant
lesions were extraintestinal tumors (figure 1), metastases or masses
(n=72), abscesses (n=63), pleural or pericardial effusions (n=13)
(figure 2) and hydronephrosis or ureteral obstruction (n=16)
(tables 4–6). 83 major clinical findings occurred in 73 of the 710
patients with IBD (10.3%) (table 4). In the group of SBD patient’s
31 major clinical findings were detected in 27 of the 182 patients
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40 of 114 SBM patients (35.1%) (table 6). The most common
findings were extraintestinal abscesses in the IBD group (69.9% of
all major clinical findings), whereas tumors, metastases or masses
were most often described in the SBD and SBM group (41.9% and
74.2%, respectively). Of all patients with findings of major clinical
significance 92.8% of the patients with IBD, 59.2% of the patients
with SBD and 35.0% of the patients with SBM underwent further
work-up. The work up was depending on the location of the
findings and included abdominal or heart ultrasound, a conven-
tional plain film of the thorax or bone structures.
Given the large percentage of patients with tumors, metastases
or masses, a systematic medical chart review of these patients was
performed. Nine patients in the IBD group presented with 10
extraintestinal findings classified as tumor, metastasis or mass. Five
out of these 10 findings (50%) were newly diagnosed in 5 patients,
whereas in 4 patients 5 extraintestinal masses were already known
before the MRE examination by either a recently performed
abdominal ultrasound examination or a CT-scan. In 12 patients
with SBD and 33 patients with SBM 7 of 13 (53.8%) and 11 of 49
(22.4%) of the findings classified as tumor, metastasis or mass were
newly detected.
Discussion
MR-E is a newly evolving imaging technology to visualize the
small bowel [31]. Aside of the lack of radiation, the advantage of
this modality compared to the conventional radiological methods
such as a small bowel follow through or conventional enteroclysis
is the ability to detect extraintestinal pathology. In our
retrospective study in nearly 60% of patients extra-enteric findings
were detected. Whereas the majority of the findings were of low
clinical importance, 35.2% were considered of high and moderate
clinical significance. Extraintestinal findings of moderate impor-
tance were detected in 19.7%, 17.3% and 18.7% in the IBD, SBD
and SBM groups. In the group of IBD and SBD patients 12.1%
and 13.7% of all extraintestinal findings were considered of major
clinical importance, whereas this was the case in 33.3% in the
patients with suspected SBM.
Additional extra-enteric findings in 20–60% of the IBD patients
are described in a number of published studies analyzing the
efficacy of MR-E or CT-E in patients with IBD [18,19,20,22,
24,25,26,27,32,33,34,35]. However, in contrast to the previous
studies, this study analyzed the clinical significance of extraintes-
tinal findings in patients with IBD undergoing MR-E. The results
demonstrate, that most often extra-enteric findings in patients with
IBD are of minor or moderate clinical significance. Findings of
major clinical importance were observed in approximately every
tenth patient (73 of 710 patients with IBD). In the majority of the
cases these were abscesses (58 of 83 major findings; 69.9%). Only
25 of the 83 major clinical findings were not abscesses (3.6% of all
findings in IBD patients), which highlight this important
complication in this patient group and indicates the value of this
cross sectional method for further therapeutic decisions in the
therapy of these patients, which is usually antibiotic therapy, CT
or ultrasound-guided drainage and/or surgery [36]. The high
Table 1. Clinical significance of extra-enteric findings in patients with inflammatory bowel disease (IBD), non-specific abdominal
symptoms (SBD) and suspected small bowel malignancies (SBM).
Patients with findings (n)* Total findings (n) Clinical significance
Major n (%) Moderate n (%) Minor n (%)
IBD (403) 689 83 (12.1) 136 (19.7) 470 (68.2)
SBD (119) 226 31 (13.7) 39 (17.3) 156 (69.0)
SBM (78) 198 66 (33.3) 37 (18.7) 95 (48.0)
*several findings per patient possible.
doi:10.1371/journal.pone.0004863.t001
Table 2. Extra-enteric findings of magnetic resonance enterography (MR-E) with minor clinical significance in patients with
inflammatory bowel diseases (IBD), non-specific abdominal symptoms (SBD) and suspected small bowel malignancies (SBM).
IBD n
% of all IBD
patients* SBD n
% of all SBD
patients* SBM n
% of all SBM
patients*
Findings total (n) 470 156 95
Most common
findings
Ovarian cysts 110 15.5% Kidney cysts 40 22.0% Kidney cysts 29 25.4%
Kidney cysts 67 9.4% Ovarian cysts 19 10.4% Liver cysts 11 9.6%
Liver cysts 50 7.0% Liver cysts 15 8.2% Small amounts of
ascites
6 5.3%
Small amounts of
ascites
50 7.0% Small amounts of
ascites
14 7.7%
Findings of minor
clinical
significance in
,5% of patients
243 68 49
*several findings per patient possible.
doi:10.1371/journal.pone.0004863.t002
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the fact, that the retrospective analysis was performed in a tertiary
care center, which normally treats more complex IBD patients.
In 5 patients new extraintestinal findings were classified as
highly suspicious of tumor, a metastasis or an abdominal mass.
Even if this comprises less than 1% of the 710 IBD patients, given
the generally young age of these patients, these findings have
profound implications for the further clinical approach.
The large number of major extraintestinal findings in the SBM
group in this retrospective study may be explained by the fact, that
this patient group underwent the examination already with a high
suspicion of an intestinal tumor, lymphoma or tumor metastases.
Additionally only 11 of the 49 findings were new findings, whereas
the majority had been previously diagnosed by another imaging
technique. Overall the patients in this group were also in average
22 and 6 years older compared to the IBD and SBD group.
Several prospective and retrospective studies report between
Table 3. Extra-enteric findings of magnetic resonance enterography (MR-E) with moderate clinical significance in patients with
inflammatory bowel diseases (IBD), non-specific abdominal symptoms (SBD) and suspected small bowel malignancies (SBM).
IBD n
% of all IBD
patients* SBD n
% of all SBD
patients* SBM n
%o fa l l
SBM
patients*
Findings total (n) 136 39 37
Most common
findings
Lymphadenopathy
# 50 7.0% Cholecysto-or
choledocholithiasis
6 3.3% Cholecysto-or
choledocholithiasis
6 5.3%
Cholecysto-or
choledocholithiasis
6 3.3% Degenerative bone
disorder
5 2.7% Degenerative bone
disorder
5 4.4%
Degenerative bone
disorder
14 2.0% Uterus myomas 4 2.2% Uterus myomas 4 3.5%
Uterine myomas 12 1.7% Splenomegaly 3 1.6% Moderate amounts of
ascites
4 3.5%
Splenomegaly 7 1.0% Lymphadenopathy
# 3 1.6% Slightly dilated kidney
collecting tubules
3 2.6%
Kidney hypoplasia 2 1.7%
Splenomegaly 2 1.7%
Abdominal wall herniation 2 1.7%
Findings of minor
clinical
significance in
,1% of patients
47 18 9
*several findings per patient possible.
*several findings per patient possible.
#considered not suspicious for lymphoma.
doi:10.1371/journal.pone.0004863.t003
Figure 1. Pancreatic mass, which turned out to be pancreatic
cancer in a 59-year old patient with Crohn’s disease.
doi:10.1371/journal.pone.0004863.g001
Figure 2. Pericardial effusion in a 47-year-old patient with
active Crohn’s disease.
doi:10.1371/journal.pone.0004863.g002
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virtual colonography for colorectal cancer screening. In this
patient population the frequency of clinically important findings
clearly depends on risk stratification. Whereas in average risk
cohorts undergoing CT-colonography 4–6% of clinically impor-
tant extracolonic findings are detected [37], the percentage of
these findings increases to 10–23% in the so called high-risk
population for colorectal cancer (defined as: family history of
colorectal cancer, personal history of polyps, new onset of anemia)
[29,38,39]. It is difficult to compare these findings with our results,
since the patient cohorts in our study are clearly different from the
patients studied in the colorectal cancer screening studies. All
patient underwent the MR-E with a clinically based suspicion of
small bowel disease, whereas in the colorectal cancer screening
studies most of the patients (except the anemia patients) were not
symptomatic.
A weakness of the presented study is it’s retrospective character.
This may especially affect the comparison of the IBD and SBD
patient groups. We classified the patients according to the
indication for the examination and not for the outcome. Therefore
some patients in the SBD group may have been later classified as
IBD and also some patients with suspected IBD may have been
later classified with e.g. irritable bowel syndrome. However, since
both groups had nearly similar prevalence rates in the 3 different
categories of the extraintestinal findings, the overall result is most
likely not affected. Retrospectively, it is also difficult to determine
the further diagnostic follow-up based on the extraintestinal MR-E
findings: often patients undergo several diagnostic procedures and
it is difficult to determine, if new diagnostic procedures were
ordered based on the MR-E findings or other clinical decisions.
In the setting of the retrospective character of the study we were
also not able to determine, how many of the extraintestinal
findings would have been detectable using other imaging
modalities, especially abdominal ultrasound. Abdominal ultra-
sound is known to have a good sensitivity and specificity in
detecting intestinal inflammation such as small bowel Crohn’s
disease, fistulizing disease or abscesses [40,41,42] Since abscesses
are one of the main extraintestinal findings in patients with
suspected or established Crohn’s disease an abdominal ultrasound
examination would be probably considerable cheaper and faster
Table 4. Major clinical extra-enteric findings in 73 patients
with suspected or proven inflammatory bowel diseases (IBD)
undergoing magnetic resonance enterography (MR-E)
(n=710).
Findings n
Total 83
Abscess 58
Urethral obstruction 5
Pleural effusion 4
Extraintestinal mass* 2
Hydronephrosis 2
Lymphadenopathy, suspicion of lymphoma* 2
Bone metastasis* 2
Pericardial effusion 1
Pleural empyema 1
Tumor adrenal gland* 1
Solid pancreatic mass* 1
Solid ovary mass* 1
Bone tumor* 1
Bone necrosis 1
Bone fracture 1
*Classified as tumor, metastasis or mass; n=10.
doi:10.1371/journal.pone.0004863.t004
Table 5. Major clinical extra-enteric findings in 27 patients
with non-specific abdominal symptoms (SBD) undergoing
magnetic resonance enterography (MR-E) (n=182).
Findings n
Total 31
Abscess 6
Pleural effusion 5
Tumor adrenal gland* 4
Extraintestinal mass* 3
Urethral obstruction 2
Bone metastasis* 2
Hydrops of gallbladder 1
Aortic aneurysm 1
Celiac artery stenosis 1
Venous thrombosis 1
Pulmonary mass* 1
Renal mass* 1
Hydronephrosis 1
Pancreatic mass* 1
Bone tumor* 1
*Classified as tumor, metastasis or mass; n=13.
doi:10.1371/journal.pone.0004863.t005
Table 6. Major clinical extra-enteric findings in 40 patients
with suspected small bowel malignancy (SBM) undergoing
magnetic resonance enterography (MR-E) (n=114).
Findings n
Total 66
Extraintestinal mass* 16
Lymphadenopathy, suspicion of lymphoma* 16
Liver metastases* 8
Adnexal mass* 4
Pleural effusion 4
Aortal aneurysm 4
Urethral obstruction 4
Bone metastases* 2
Hydronephrosis 2
Abscess 1
Prostate cancer* 1
Mass rectus abdominis muscle* 1
Bone tumor* 1
Bone necrosis 1
Bone fracture 1
*Classified as tumor, metastasis or mass; n=49.
doi:10.1371/journal.pone.0004863.t006
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the sensitivity of abdominal ultrasound in detecting extraintestinal
pathologies other than abscesses or fistulizing disease has never
been determined in comparison e.g. with MRI or CT.
In conclusion, in more than half of the patients undergoing MR-
E additional extra-enteric findings were detected, the majority of
extra-enteric MR-E findings being of low clinical importance, but
approximately one third of the patients being diagnosed with
findings of moderate or major clinical significance. Especially in
the group of IBD patients, in whom the majority of the described
major clinical findings were abscesses, cross sectional imaging
MR-E provides additional important clinical information com-
pared to the conventional small bowel techniques such as SBFT or
SB-enteroclysis.
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